A comprehensive analysis of 956 FDA-approved radiology AI devices reveals a troubling disconnect: while software defects drive most failures, manufacturers rarely implement corresponding safety updates or maintain integrated risk management systems. Original paper: The absence of full lifecycle risk management for AI-based medical devices in radiology. — NPJ Digital Medicine, May 2026. 📄 Read the article